PD-1 and LAG-3 synergize to drive tumour-infiltration of T cytotoxic cells in NSCLC tumours

被引：0
|
作者：
Juncker-Jensen, A. [1 ]
Nagy, M. [2 ]
Kuo, J. [2 ]
Leones, E. [2 ]
Sahafi, F. [2 ]
Pham, K. [2 ]
Parnell, E. [2 ]
机构：
[1] NeoGenomics, Pharma MultiOmyx, Aliso Viejo, CA USA
[2] NeoGenomics, MultiOmyx, Aliso Viejo, CA USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
131P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Blockade of PD-1 and LAG-3 expression on CD8+T cells promotes the tumoricidal effects of CD8+T cells
    Ma, Jiajia
    Yan, Shufang
    Zhao, Ying
    Yan, Huifang
    Zhang, Qian
    Li, Xinxia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Expression of PD-1/LAG-3 and cytokine production by CD4+ T cells during infection with Plasmodium parasites
    Doe, Henrietta T.
    Kimura, Daisuke
    Miyakoda, Mana
    Kimura, Kazumi
    Akbari, Masoud
    Yui, Katsuyuki
    MICROBIOLOGY AND IMMUNOLOGY, 2016, 60 (02) : 121 - 131
  • [23] Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+T cells to promote antitumor immunity
    Cillo, Anthony R.
    Cardello, Carly
    Shan, Feng
    Karapetyan, Lilit
    Kunning, Sheryl
    Sander, Cindy
    Rush, Elizabeth
    Karunamurthy, Arivarasan
    Massa, Ryan C.
    Rohatgi, Anjali
    Workman, Creg J.
    Kirkwood, John M.
    Bruno, Tullia C.
    Vignali, Dario A. A.
    CELL, 2024, 187 (16)
  • [24] LAG-3 expression in advanced basal cell carcinoma (BCC) and tumor regression following combined PD-1/LAG-3 blockade
    Deutsch, J. S.
    Schenk, K. M.
    Soni, A.
    Lipson, E.
    Taube, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S271 - S271
  • [25] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [26] No more LAGging behind PD-1: uncovering the unique role of LAG-3 in T-cell exhaustion
    Jo, Yunju
    Jin, Hyung-seung
    Park, Yoon
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (12) : 1351 - 1353
  • [27] Expression of LAG-3 and NY-ESO-1 In Tumor Cells is Promising Biomarker Predicting Durable Clinical Benefit of PD-1 Blockade in Advanced NSCLC
    Jang, H. R.
    Kim, S. H.
    Suh, K. J.
    Kim, Y. J.
    Kim, M. S.
    Keam, B.
    Kim, T. M.
    Chung, J.
    Kim, D.
    Heo, D. S.
    Lee, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S394 - S394
  • [28] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    CANCER RESEARCH, 2015, 75
  • [29] PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
    Zahm, Christopher D.
    Moseman, Jena E.
    Delmastro, Lauren E.
    G. Mcneel, Douglas
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [30] Simultaneous measurement and clinical significance of PD-1, LAG-3 and TIM-3 in non-small cell lung cancer (NSCLC)
    Datar, Ila J.
    Wang, Jun
    Mani, Nikita
    Villarroel-Espindola, Franz
    Ryan, Patrick
    Sanmamed, Miguel F.
    McEachern, Kristen
    Jenkins, David
    Rimm, David L.
    Chen, Leiping
    Herbst, Roy
    Schalper, Kurt
    CANCER RESEARCH, 2017, 77
12345